// App-Quantinova.ai

P060 : Selective, Discontinuous Reduction of B and T Lymphocytes and NK Cells in Patients with Early, Relapsing MS after administration

Researchers

Presenter

  • Ursula Boschert

Principal Investigators

  • Olaf Stuve

  • Per Soelberg-Sorensen

  • Gavin Giovannoni

  • Thomas P Leist

  • Yann Hyvert

  • Doris Damian

Medical Centers

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • 2Danish Multiple Sclerosis Registry, Copenhagen University Hospital København Ø Denmark

  • Queen Mary University of London, William Harvey Research Institute, London, United Kingdom

  • Thomas Jefferson University, Philadelphia, PA

  • EMD Serono, Inc, Billerica, MA

Locations

  • United States

  • Denmark

  • United Kingdom

Companies

  • EMD Serono Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Exostosin Glycosyltransferase 1

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved